Andrew H. Woo serves as Executive at Alzamend Neuro, Inc., where they oversee executive responsibilities. Since joining the company, Andrew H. Woo has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Mar 15, 2022 involved exercising options for 50,000 shares valued at $0.
Andrew H. Woo currently holds 100,000 shares of Alzamend Neuro, Inc. (ALZN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Andrew H. Woo has been a net neutral trader of ALZN stock. They have purchased $0 and sold $0 worth of shares.
Andrew H. Woo's most recent insider trade was on Mar 15, 2022, when they sold 50,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| 47,222 |
| $N/A |
| Discretionary |
| Sep 13, 2021 | ALZN | $0 | Option Exercise | 2,778 | $N/A | Discretionary |